Literature DB >> 4075358

Effect of hyperaemia on thallium-201 redistribution in normal canine myocardium.

J A Leppo, R D Okada, H W Strauss, G M Pohost.   

Abstract

The specific effect of hyperaemia on thallium redistribution is not known. Therefore we evaluated the effect of initial (group A) and delayed (group B) hyperaemia on thallium kinetics in normal canine myocardium. In group A dogs (n = 14) adenosine was infused into the left circumflex artery (LCx) prior to thallium injection and was continued for either 5, 30 or 120 min after thallium administration. In group B dogs (n = 10) LCx adenosine was begun 10 min post thallium injection and continued for 2 h. Radioactive microspheres were injected simultaneously with thallium and just prior to death in all but the 5 min experiments. The region of the left anterior descending artery (LAD) served as a normal control for each heart. The mean LCx/LAD flow ratio in all group A hearts was 3.81 +/- 1.24 (SD) and the final thallium LCx/LAD ratios averaged 2.29 +/- 0.26, 1.52 +/- 0.27 and 0.93 +/- 0.16 at 5, 30 and 120 min respectively, which represents a significant redistribution of thallium (p less than 0.05). In group B hearts, the mean LCx/LAD flow ratio was 1.06 +/- 0.07 during thallium injection and after LCx adenosine infusion the flow ratio rose to 2.91 +/- 0.75 (p less than 0.001). This resulted in a final thallium LCx/LAD ratio of 0.96 +/- 0.07 which was significantly less than the initial microsphere determined flow ratio (p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4075358     DOI: 10.1093/cvr/19.11.679

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  1 in total

1.  Rest-redistribution thallium-201 myocardial scintigraphic study in cardiac amyloidosis.

Authors:  K Kodama; M Hamada; T Kuwahara; M Nakamura; Y Shigematsu; K Hiwada; T Iwata; Y Hoshii; T Ishihara
Journal:  Int J Card Imaging       Date:  1999-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.